CLINICAL_TRIALS
trial_result
· 2019-03-15
Clinical Trial Update: A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes [Phase 1]
Summary
Phase 1 trial investigating LY2605541 and glargine with exercise in adults with type 1 diabetes; study completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2019-03-15